Optimization of techniques for multiple platform testing in small, precious samples such as human chorionic villus sampling

Prenat Diagn. 2016 Nov;36(11):1061-1070. doi: 10.1002/pd.4936. Epub 2016 Nov 7.

Abstract

Background: Multiple testing to understand global changes in gene expression based on genetic and epigenetic modifications is evolving. Chorionic villi, obtained for prenatal testing, is limited, but can be used to understand ongoing human pregnancies. However, optimal storage, processing and utilization of CVS for multiple platform testing have not been established.

Results: Leftover CVS samples were flash-frozen or preserved in RNAlater. Modifications to standard isolation kits were performed to isolate quality DNA and RNA from samples as small as 2-5 mg. RNAlater samples had significantly higher RNA yields and quality and were successfully used in microarray and RNA-sequencing (RNA-seq). RNA-seq libraries generated using 200 versus 800-ng RNA showed similar biological coefficients of variation. RNAlater samples had lower DNA yields and quality, which improved by heating the elution buffer to 70 °C. Purification of DNA was not necessary for bisulfite-conversion and genome-wide methylation profiling. CVS cells were propagated and continue to express genes found in freshly isolated chorionic villi.

Conclusions: CVS samples preserved in RNAlater are superior. Our optimized techniques provide specimens for genetic, epigenetic and gene expression studies from a single small sample which can be used to develop diagnostics and treatments using a systems biology approach in the prenatal period. © 2016 John Wiley & Sons, Ltd.

MeSH terms

  • Cell Culture Techniques
  • Chorionic Villi Sampling*
  • Clinical Laboratory Techniques*
  • DNA / isolation & purification
  • Female
  • Humans
  • Pregnancy
  • RNA / isolation & purification

Substances

  • RNA
  • DNA